USFDA gives final nod to Zydus Lifesciences’ generic version of insomnia drug

Zydus Lifesciences last week said it has received final approval from the United States Food and Drug Administration (USFDA) to market its generic version of triazolam tablets used on a short-term basis to treat insomnia.

Edits by EP News Bureau